Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had revenue of $35.07M in the quarter ending March 31, 2026, with 16.83% growth. This brings the company's revenue in the last twelve months to $151.12M, up 6.33% year-over-year. In the year 2025, Karyopharm Therapeutics had annual revenue of $146.07M with 0.57% growth.

• Revenue (ttm): $151.12M
• Revenue Growth: +6.33%
• P/S Ratio: 1.36
• Revenue / Employee: $662,798
• Employees: 228
• Market Cap: 204.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	146.07M	830.00K	0.57%
Dec 31, 2024	145.24M	-796.00K	-0.55%
Dec 31, 2023	146.03M	-11.04M	-7.03%
Dec 31, 2022	157.07M	-52.75M	-25.14%
Dec 31, 2021	209.82M	101.73M	94.12%
Dec 31, 2020	108.09M	67.19M	164.31%
Dec 31, 2019	40.89M	10.56M	34.80%
Dec 31, 2018	30.34M	28.73M	1,790.09%
Dec 31, 2017	1.61M	1.45M	942.21%
Dec 31, 2016	154.00K	-96.00K	-38.40%
Dec 31, 2015	250.00K	21.00K	9.17%
Dec 31, 2014	229.00K	-158.00K	-40.83%
Dec 31, 2013	387.00K	-247.00K	-38.96%
Dec 31, 2012	634.00K	482.00K	317.11%
Dec 31, 2011	152.00K	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 5, 2026

Data Sources Report a data error